文献速递头颈部肿瘤放疗

鼻咽癌Ib区淋巴结转移的危险因素及其选择性预防照射的临床结局:一项真实世界研究

Risk factors of level Ib lymph node metastasis and clinical outcome of its selectively prophylactic irradiation in nasopharyngeal carcinoma: A real-world study.
PubMed 文献 · Radiother Oncol · 2024-11-12

该真实世界研究纳入518例接受根治性IMRT的鼻咽癌患者,分析Ib区淋巴结转移的危险因素。同侧下颌下腺侵犯是Ib区淋巴结转移的独立危险因素。在无同侧Ib区淋巴结转移及下颌下腺侵犯的患者中,省略Ib区预防照射未增加Ib区无复发生存率及区域无复发生存率,并降低口干发生率。

要点

  • 同侧下颌下腺侵犯是鼻咽癌Ib区淋巴结转移的独立危险因素。
  • 无同侧Ib区淋巴结转移及下颌下腺侵犯者省略Ib区预防照射未增加Ib区无复发生存率及区域无复发生存率。
  • 省略Ib区预防照射者1年≥2级口干发生率为28.0%,低于单侧38.3%和双侧90.0%。

核心结论

  • 同侧下颌下腺侵犯是鼻咽癌Ib区淋巴结转移的独立危险因素。
  • 在无同侧Ib区淋巴结转移及下颌下腺侵犯的患者中省略Ib区预防照射未增加Ib区无复发生存率及区域无复发生存率,并降低口干发生率。
  • 作者认为需要进一步开展多中心前瞻性随机临床试验。

研究设计与样本

  • 真实世界研究,纳入518例接受根治性IMRT的鼻咽癌患者。
  • 双侧分析原发肿瘤侵犯结构和颈部淋巴结转移水平以评估Ib区淋巴结转移危险因素。
  • 有Ib区淋巴结转移和下颌下腺侵犯的患者接受Ib区预防照射。
  • 在Ib区淋巴结阴性患者中比较省略、单侧或双侧Ib区预防照射的Ib区无复发生存率、区域无复发生存率及IMRT后1年≥2级口干发生率。

主要发现

  • 13例(2.5%)患者共18侧存在Ib区淋巴结转移。
  • 同侧下颌下腺侵犯是Ib区淋巴结转移的独立危险因素。
  • 中位随访98.0个月,Ib区淋巴结阴性患者中省略预防照射组、单侧预防照射组、双侧预防照射组的5年Ib区无复发生存率分别为99.7%、100%、97.5%(P=0.110)。
  • 上述三组的5年区域无复发生存率分别为98.0%、92.1%、95.1%(P=0.120)。
  • 上述三组IMRT后1年≥2级口干发生率分别为28.0%、38.3%、90.0%(P<0.001)。

临床怎么用

  • 作者结论认为,在无同侧Ib区淋巴结转移及下颌下腺侵犯的患者中省略Ib区预防照射未增加Ib区无复发生存率及区域无复发生存率,并降低口干发生率。
  • 作者认为需要进一步开展多中心前瞻性随机临床试验。

局限性

  • 作者认为需要进一步开展多中心前瞻性随机临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the risk factor of level Ib lymph node metastasis (LNM) and the clinical outcome of its selectively prophylactic irradiation (pRT) in nasopharyngeal carcinoma (NPC) patients treated with IMRT. METHODS: 518 NPC patients receiving radical IMRT were collected. The structures of primary tumor invasions and neck LNM levels were analyzed bilaterally to estimate the risk factors of level Ib LNM. Patients with level Ib LNM and submandibular gland (SMG) invasion received level Ib pRT. The level Ib recurrence-free survival (RFSIb), regional recurrence-free survival (RRFS), and the incidence of ≥ grade 2 xerostomia at 1-year post-IMRT were compared in negative level Ib LNM patients who omitted, received unilateral, or bilateral level Ib pRT. RESULTS: Thirteen (2.5 %) patients with 18 sides had level Ib LNM. Ipsilateral SMG invasion was an independent risk factor for level Ib LNM. With a median follow-up time of 98.0 months, the 5-year RFSIb, 5-year RRFS and the incidence of xerostomia ≥ grade 2 at 1-year post-IMRT in negative level Ib LNM patients who omitted pRT, received unilateral, bilateral pRT to the level Ib were 99.7 % vs.100 % vs. 97.5 % (P = 0.110), 98.0 % vs. 92.1 % vs. 95.1 % (P = 0.120) and 28.0 % vs. 38.3 % vs. 90.0 % (P < 0.001), respectively. CONCLUSIONS: Our study revealed that ipsilateral SMG invasion was the independent risk factor for the level Ib LNM. Omitting pRT in patients without ipsilateral level Ib LNM and SMG invasion did not increase the RFSIB and RRFS, and reduced the incidence of xerostomia. Further multi-center prospective randomized clinical trial is warranted.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Zhu MY, Wu HJ, Fang T, et al. Risk factors of level Ib lymph node metastasis and clinical outcome of its selectively prophylactic irradiation in nasopharyngeal carcinoma: A real-world study. Radiother Oncol. 2024. PMID: 39537031. doi:10.1016/j.radonc.2024.110620

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。